Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Marco Maruzzo, Juan Martin-Liberal, Christina Messiou, Aisha Miah, Khin Thway, Rolyn Alvarado, Ian Judson, Charlotte Benson

ABSTRACT

BACKGROUND: Solitary Fibrous Tumour (SFT) is a rare soft tissue neoplasm, described in several locations in the body. It is classified as intermediate malignant potential with low risk of metastasis and has a low tendency to recur after primary surgery. METHODS: We performed a prospective data collection of the patients with SFT presented to the Royal Marsden Hospital from January to December 2013, and treated with pazopanib in first line. Demographics, anatomic primary sites, treatment and survival outcomes were collected from patients' electronic records. RESULTS: 13 patients (54% females) were identified with a median age of 51 years (range 37-77). Most of the patients (77%) were diagnosed with extra-thoracic SFT. All the patients received first line treatment with pazopanib for metastatic disease. Median overall survival (OS) was 13.3 months. Median progression free survival (PFS) was 4.7 months. No statistically significant difference was found in OS and PFS between primary thoracic SFT and primary extra-thoracic SFT. According to RECIST, one partial response (9%) and eight disease stabilizations (73%) were found as best responses. Using Choi criteria, there were 5 partial responses (46%) and 4 stabilizations (36%). CONCLUSION: Our prospective data confirm that anti-angiogenic drugs are active in SFT. PFS and overall response do not appear significantly lower than other reported series on the same disease. Furthermore, pazopanib is a drug already licensed in soft tissue sarcomas and these data suggest its activity also in this particular subtype of sarcomas. More... »

PAGES

5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13569-015-0022-2

DOI

http://dx.doi.org/10.1186/s13569-015-0022-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046212813

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25664166


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maruzzo", 
        "givenName": "Marco", 
        "id": "sg:person.0715477107.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715477107.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martin-Liberal", 
        "givenName": "Juan", 
        "id": "sg:person.01165767756.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165767756.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Radiology Department, The Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Messiou", 
        "givenName": "Christina", 
        "id": "sg:person.01107113050.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107113050.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miah", 
        "givenName": "Aisha", 
        "id": "sg:person.01062533323.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062533323.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Pathology Department, The Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thway", 
        "givenName": "Khin", 
        "id": "sg:person.01023745035.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745035.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alvarado", 
        "givenName": "Rolyn", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Judson", 
        "givenName": "Ian", 
        "id": "sg:person.01132707630.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132707630.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benson", 
        "givenName": "Charlotte", 
        "id": "sg:person.01316126434.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316126434.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2407-13-109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000451295", 
          "https://doi.org/10.1186/1471-2407-13-109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9249-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004621655", 
          "https://doi.org/10.1007/s10637-009-9249-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9249-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004621655", 
          "https://doi.org/10.1007/s10637-009-9249-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2045-3329-2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006877461", 
          "https://doi.org/10.1186/2045-3329-2-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013138672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017577314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/0284186x.2011.626450", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019576097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.3049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020547992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2012.83", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021050243", 
          "https://doi.org/10.1038/modpathol.2012.83"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-013-0023-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025613068", 
          "https://doi.org/10.1007/s10637-013-0023-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-013-0023-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025613068", 
          "https://doi.org/10.1007/s10637-013-0023-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(197804)41:4<1256::aid-cncr2820410406>3.0.co;2-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030343759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mds143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030622852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.2512081403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031436692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2009.02.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032437323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033633830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033633830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2559.1997.2400897.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034862549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2559.1997.2400897.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034862549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004280050054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035944584", 
          "https://doi.org/10.1007/s004280050054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(07)70175-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037193917"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2010.02.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039115658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)60651-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040046880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-009-0348-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041835837", 
          "https://doi.org/10.1007/s12094-009-0348-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-009-0348-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041835837", 
          "https://doi.org/10.1007/s12094-009-0348-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.13-s2-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045098601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-0776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046797776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.mph.0000212903.61276.4b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048631007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.mph.0000212903.61276.4b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048631007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.9764", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052849919"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Solitary Fibrous Tumour (SFT) is a rare soft tissue neoplasm, described in several locations in the body. It is classified as intermediate malignant potential with low risk of metastasis and has a low tendency to recur after primary surgery.\nMETHODS: We performed a prospective data collection of the patients with SFT presented to the Royal Marsden Hospital from January to December 2013, and treated with pazopanib in first line. Demographics, anatomic primary sites, treatment and survival outcomes were collected from patients' electronic records.\nRESULTS: 13 patients (54% females) were identified with a median age of 51\u00a0years (range 37-77). Most of the patients (77%) were diagnosed with extra-thoracic SFT. All the patients received first line treatment with pazopanib for metastatic disease. Median overall survival (OS) was 13.3\u00a0months. Median progression free survival (PFS) was 4.7\u00a0months. No statistically significant difference was found in OS and PFS between primary thoracic SFT and primary extra-thoracic SFT. According to RECIST, one partial response (9%) and eight disease stabilizations (73%) were found as best responses. Using Choi criteria, there were 5 partial responses (46%) and 4 stabilizations (36%).\nCONCLUSION: Our prospective data confirm that anti-angiogenic drugs are active in SFT. PFS and overall response do not appear significantly lower than other reported series on the same disease. Furthermore, pazopanib is a drug already licensed in soft tissue sarcomas and these data suggest its activity also in this particular subtype of sarcomas.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13569-015-0022-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "name": "Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience", 
    "pagination": "5", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "dc2279f0ee8f02627d3bff4cd9af59470bfa4adef41f161b6d9c013299d995db"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25664166"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101577890"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13569-015-0022-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046212813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13569-015-0022-2", 
      "https://app.dimensions.ai/details/publication/pub.1046212813"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88217_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs13569-015-0022-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0022-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0022-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0022-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13569-015-0022-2'


 

This table displays all metadata directly associated to this object as RDF triples.

200 TRIPLES      21 PREDICATES      54 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13569-015-0022-2 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nb06e77bde36243f58dbd0ddf4c6c7a76
4 schema:citation sg:pub.10.1007/s004280050054
5 sg:pub.10.1007/s10637-009-9249-1
6 sg:pub.10.1007/s10637-013-0023-z
7 sg:pub.10.1007/s12094-009-0348-4
8 sg:pub.10.1038/modpathol.2012.83
9 sg:pub.10.1186/1471-2407-13-109
10 sg:pub.10.1186/2045-3329-2-2
11 https://doi.org/10.1002/1097-0142(197804)41:4<1256::aid-cncr2820410406>3.0.co;2-v
12 https://doi.org/10.1002/cncr.10328
13 https://doi.org/10.1002/cncr.26098
14 https://doi.org/10.1016/j.critrevonc.2010.02.012
15 https://doi.org/10.1016/j.ejca.2008.10.026
16 https://doi.org/10.1016/j.ejso.2009.02.015
17 https://doi.org/10.1016/s0140-6736(12)60651-5
18 https://doi.org/10.1016/s1470-2045(07)70175-4
19 https://doi.org/10.1046/j.1365-2559.1997.2400897.x
20 https://doi.org/10.1093/annonc/mds143
21 https://doi.org/10.1097/01.mph.0000212903.61276.4b
22 https://doi.org/10.1111/j.1365-2559.2005.02290.x
23 https://doi.org/10.1148/radiol.2512081403
24 https://doi.org/10.1158/1078-0432.ccr-13-0776
25 https://doi.org/10.1200/jco.2006.07.3049
26 https://doi.org/10.1200/jco.2009.23.9764
27 https://doi.org/10.1634/theoncologist.13-s2-4
28 https://doi.org/10.3109/0284186x.2011.626450
29 schema:datePublished 2015-12
30 schema:datePublishedReg 2015-12-01
31 schema:description BACKGROUND: Solitary Fibrous Tumour (SFT) is a rare soft tissue neoplasm, described in several locations in the body. It is classified as intermediate malignant potential with low risk of metastasis and has a low tendency to recur after primary surgery. METHODS: We performed a prospective data collection of the patients with SFT presented to the Royal Marsden Hospital from January to December 2013, and treated with pazopanib in first line. Demographics, anatomic primary sites, treatment and survival outcomes were collected from patients' electronic records. RESULTS: 13 patients (54% females) were identified with a median age of 51 years (range 37-77). Most of the patients (77%) were diagnosed with extra-thoracic SFT. All the patients received first line treatment with pazopanib for metastatic disease. Median overall survival (OS) was 13.3 months. Median progression free survival (PFS) was 4.7 months. No statistically significant difference was found in OS and PFS between primary thoracic SFT and primary extra-thoracic SFT. According to RECIST, one partial response (9%) and eight disease stabilizations (73%) were found as best responses. Using Choi criteria, there were 5 partial responses (46%) and 4 stabilizations (36%). CONCLUSION: Our prospective data confirm that anti-angiogenic drugs are active in SFT. PFS and overall response do not appear significantly lower than other reported series on the same disease. Furthermore, pazopanib is a drug already licensed in soft tissue sarcomas and these data suggest its activity also in this particular subtype of sarcomas.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree true
35 schema:isPartOf N0de89fd2a0584ea7b9d53762019145ae
36 Nb26a63369432463cb6dafc6300494fc3
37 sg:journal.1046367
38 schema:name Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
39 schema:pagination 5
40 schema:productId N599eed8d4f1c4cf08f2eb6d1aff150d3
41 N647dd4db04ff424fbee8155877e8df43
42 N7c387125002348008adb8e6684d15dec
43 Nabed850dc0f0443982e6678fb31046fe
44 Nd034a0d5f35c43d89a759b0896221e5e
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046212813
46 https://doi.org/10.1186/s13569-015-0022-2
47 schema:sdDatePublished 2019-04-11T13:06
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N094fe55319a347259b36d9e8ebcbe4ee
50 schema:url http://link.springer.com/10.1186%2Fs13569-015-0022-2
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N094fe55319a347259b36d9e8ebcbe4ee schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 N0de89fd2a0584ea7b9d53762019145ae schema:issueNumber 1
57 rdf:type schema:PublicationIssue
58 N14e66690eec04ffb8a432ecd40d9f759 rdf:first sg:person.01023745035.11
59 rdf:rest N80cce359bf9b4bc99680f2d756282442
60 N16ab739f687f4492b9b83bb1857715ba rdf:first sg:person.01062533323.33
61 rdf:rest N14e66690eec04ffb8a432ecd40d9f759
62 N46d4c52877fd4992805084275d068aab schema:affiliation https://www.grid.ac/institutes/grid.5072.0
63 schema:familyName Alvarado
64 schema:givenName Rolyn
65 rdf:type schema:Person
66 N599eed8d4f1c4cf08f2eb6d1aff150d3 schema:name nlm_unique_id
67 schema:value 101577890
68 rdf:type schema:PropertyValue
69 N647dd4db04ff424fbee8155877e8df43 schema:name doi
70 schema:value 10.1186/s13569-015-0022-2
71 rdf:type schema:PropertyValue
72 N7c387125002348008adb8e6684d15dec schema:name pubmed_id
73 schema:value 25664166
74 rdf:type schema:PropertyValue
75 N80cce359bf9b4bc99680f2d756282442 rdf:first N46d4c52877fd4992805084275d068aab
76 rdf:rest Nb7082b786b7e4c6ab97240e1429d744e
77 Nabed850dc0f0443982e6678fb31046fe schema:name readcube_id
78 schema:value dc2279f0ee8f02627d3bff4cd9af59470bfa4adef41f161b6d9c013299d995db
79 rdf:type schema:PropertyValue
80 Nb06e77bde36243f58dbd0ddf4c6c7a76 rdf:first sg:person.0715477107.17
81 rdf:rest Nb518fa425b604c43873b7bc310febaf7
82 Nb26a63369432463cb6dafc6300494fc3 schema:volumeNumber 5
83 rdf:type schema:PublicationVolume
84 Nb518fa425b604c43873b7bc310febaf7 rdf:first sg:person.01165767756.07
85 rdf:rest Nb5c0ffc9e2024b8fb20bac3acf4ee4d5
86 Nb5c0ffc9e2024b8fb20bac3acf4ee4d5 rdf:first sg:person.01107113050.31
87 rdf:rest N16ab739f687f4492b9b83bb1857715ba
88 Nb7082b786b7e4c6ab97240e1429d744e rdf:first sg:person.01132707630.61
89 rdf:rest Nbf3425605daf451a8216e5bf07810a91
90 Nbf3425605daf451a8216e5bf07810a91 rdf:first sg:person.01316126434.16
91 rdf:rest rdf:nil
92 Nd034a0d5f35c43d89a759b0896221e5e schema:name dimensions_id
93 schema:value pub.1046212813
94 rdf:type schema:PropertyValue
95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
96 schema:name Medical and Health Sciences
97 rdf:type schema:DefinedTerm
98 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
99 schema:name Oncology and Carcinogenesis
100 rdf:type schema:DefinedTerm
101 sg:journal.1046367 schema:issn 2045-3329
102 schema:name Clinical Sarcoma Research
103 rdf:type schema:Periodical
104 sg:person.01023745035.11 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
105 schema:familyName Thway
106 schema:givenName Khin
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745035.11
108 rdf:type schema:Person
109 sg:person.01062533323.33 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
110 schema:familyName Miah
111 schema:givenName Aisha
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062533323.33
113 rdf:type schema:Person
114 sg:person.01107113050.31 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
115 schema:familyName Messiou
116 schema:givenName Christina
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107113050.31
118 rdf:type schema:Person
119 sg:person.01132707630.61 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
120 schema:familyName Judson
121 schema:givenName Ian
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132707630.61
123 rdf:type schema:Person
124 sg:person.01165767756.07 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
125 schema:familyName Martin-Liberal
126 schema:givenName Juan
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165767756.07
128 rdf:type schema:Person
129 sg:person.01316126434.16 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
130 schema:familyName Benson
131 schema:givenName Charlotte
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316126434.16
133 rdf:type schema:Person
134 sg:person.0715477107.17 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
135 schema:familyName Maruzzo
136 schema:givenName Marco
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715477107.17
138 rdf:type schema:Person
139 sg:pub.10.1007/s004280050054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035944584
140 https://doi.org/10.1007/s004280050054
141 rdf:type schema:CreativeWork
142 sg:pub.10.1007/s10637-009-9249-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004621655
143 https://doi.org/10.1007/s10637-009-9249-1
144 rdf:type schema:CreativeWork
145 sg:pub.10.1007/s10637-013-0023-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1025613068
146 https://doi.org/10.1007/s10637-013-0023-z
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/s12094-009-0348-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041835837
149 https://doi.org/10.1007/s12094-009-0348-4
150 rdf:type schema:CreativeWork
151 sg:pub.10.1038/modpathol.2012.83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021050243
152 https://doi.org/10.1038/modpathol.2012.83
153 rdf:type schema:CreativeWork
154 sg:pub.10.1186/1471-2407-13-109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000451295
155 https://doi.org/10.1186/1471-2407-13-109
156 rdf:type schema:CreativeWork
157 sg:pub.10.1186/2045-3329-2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006877461
158 https://doi.org/10.1186/2045-3329-2-2
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1002/1097-0142(197804)41:4<1256::aid-cncr2820410406>3.0.co;2-v schema:sameAs https://app.dimensions.ai/details/publication/pub.1030343759
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1002/cncr.10328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017577314
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1002/cncr.26098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013138672
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/j.critrevonc.2010.02.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039115658
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/j.ejso.2009.02.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032437323
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s0140-6736(12)60651-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040046880
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/s1470-2045(07)70175-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037193917
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1046/j.1365-2559.1997.2400897.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034862549
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1093/annonc/mds143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030622852
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1097/01.mph.0000212903.61276.4b schema:sameAs https://app.dimensions.ai/details/publication/pub.1048631007
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1111/j.1365-2559.2005.02290.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033633830
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1148/radiol.2512081403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031436692
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1158/1078-0432.ccr-13-0776 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046797776
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1200/jco.2006.07.3049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020547992
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1200/jco.2009.23.9764 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052849919
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1634/theoncologist.13-s2-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045098601
193 rdf:type schema:CreativeWork
194 https://doi.org/10.3109/0284186x.2011.626450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019576097
195 rdf:type schema:CreativeWork
196 https://www.grid.ac/institutes/grid.5072.0 schema:alternateName Royal Marsden NHS Foundation Trust
197 schema:name Pathology Department, The Royal Marsden NHS Foundation Trust, London, UK
198 Radiology Department, The Royal Marsden NHS Foundation Trust, London, UK
199 Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK
200 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...